ReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium
Provided By GlobeNewswire
Last update: May 2, 2025
Vagal Neuromodulation Offers a Novel Approach to Treating Diabetes and Hypoglycemia
Device Demonstrates the Ability to Modulate Glucose Levels Without Cardiac Side Effects, Overcoming a Key Limitation Of Conventional Vagal Stimulation Techniques
Read more at globenewswire.com0.42
+0.08 (+23.89%)
Find more stocks in the Stock Screener
RSLS Latest News and Analysis
16 hours ago - ChartmillCurious about the most active stocks on Friday?Get a pulse on the US markets on Friday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
20 hours ago - ChartmillWhich stocks are gapping on Friday?There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
12 days ago - ChartmillHere are the top movers in Monday's session.Curious about what's happening in today's session? Check out the latest stock movements and price changes.
12 days ago - ChartmillMost active stocks in Monday's sessionCurious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
12 days ago - ChartmillTop movers analysis in the middle of the day on 2025-04-21: top gainers and losers in today's session.Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
12 days ago - ChartmillThe market is filled with gapping stocks in Monday's session.Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
